Elite in Major Depression

Sidney H. Kennedy

200 Elizabeth St, 
Toronto, ON, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Elite in Major Depression
200 Elizabeth St, 
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Sidney Kennedy practices in Toronto, Canada. Mr. Kennedy is rated as an Elite expert by MediFind in the treatment of Major Depression. His top areas of expertise are Major Depression, Bipolar Disorder (BPD), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, and Deep Brain Stimulation.

His clinical research consists of co-authoring 377 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 125 articles and participated in 2 clinical trials in the study of Major Depression.

Gender
Male

Locations

200 Elizabeth St, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
Enrollment Status: Recruiting
Publish Date: March 13, 2024
Intervention Type: Drug
Study Phase: Phase 4
Mitigating Suicide Risk During the COVID-19 Pandemic Via Telehealth Using an Intensive Single Session of Brief Skills for Safer Living
Mitigating Suicide Risk During the COVID-19 Pandemic Via Telehealth Using an Intensive Single Session of Brief Skills for Safer Living
Enrollment Status: Completed
Publish Date: November 09, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
Investigations on the Efficacy of Ketamine in Depression in Comparison to Electroconvulsive Therapy
Investigations on the Efficacy of Ketamine in Depression in Comparison to Electroconvulsive Therapy
Enrollment Status: Suspended
Publish Date: September 01, 2023
Intervention Type: Procedure, Drug
Study Drug: Ketamine
Study Phase: Phase 3
Integrated Biological Markers for the Prediction of Treatment Response in Depression: Validation Study
Integrated Biological Markers for the Prediction of Treatment Response in Depression: Validation Study
Enrollment Status: Completed
Publish Date: March 02, 2023
Intervention Type: Drug
Study Drugs: Escitalopram, Brexpiprazole
Study Phase: Phase 3
Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study
Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study
Enrollment Status: Completed
Publish Date: May 24, 2022
A Collaborative Investigation of Predictors of Relapse in Major Depressive Disorder: CAN-BIND-1 Extension Study
A Collaborative Investigation of Predictors of Relapse in Major Depressive Disorder: CAN-BIND-1 Extension Study
Enrollment Status: Completed
Publish Date: November 04, 2020
Intervention Type: Other
View 5 Less Clinical Trials

377 Total Publications

The Canadian Network for Mood and Anxiety Treatments Task Force Recommendations for the Use of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplants in Adults With Major Depressive Disorder: Recommandations du Groupe de travail du Réseau canadien pour le traitement des troubles de l'humeur et de l'anxiété (Canadian Network for Mood and Anxiety Treatments, CANMAT) concernant l'utilisation des probiotiques, des prébiotiques, des symbiotiques et de la transplantation de microbiote fécal chez les adultes atteints de trouble dépressif majeur.
The Canadian Network for Mood and Anxiety Treatments Task Force Recommendations for the Use of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplants in Adults With Major Depressive Disorder: Recommandations du Groupe de travail du Réseau canadien pour le traitement des troubles de l'humeur et de l'anxiété (Canadian Network for Mood and Anxiety Treatments, CANMAT) concernant l'utilisation des probiotiques, des prébiotiques, des symbiotiques et de la transplantation de microbiote fécal chez les adultes atteints de trouble dépressif majeur.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: November 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kennedy's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile